Company Filing History:
Years Active: 2010-2015
Title: Frank Dullweber: Innovator in HDAC Inhibitors
Introduction
Frank Dullweber is a notable inventor based in Constance, DE. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that serve as effective HDAC inhibitors. With a total of 4 patents to his name, Dullweber's work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents, Dullweber has developed sulfonylpyrroles, which are compounds of a specific formula (I). These compounds, in which R1, R2, R3, R4, R5, R6, and R7 have the meanings indicated in the description, are noted for their effectiveness as HDAC inhibitors. This innovation holds promise for advancing therapeutic options in various medical conditions.
Career Highlights
Dullweber is currently associated with 4SC AG, a company that focuses on the development of innovative therapies for cancer and autoimmune diseases. His work at 4SC AG has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of new treatment modalities.
Collaborations
Some of his notable coworkers include Thomas Maier and Thomas Beckers, who collaborate with him in various research and development projects. Their combined expertise enhances the innovative capacity of their team.
Conclusion
Frank Dullweber's contributions to the field of HDAC inhibitors exemplify the importance of innovation in pharmaceuticals. His work continues to pave the way for new therapeutic solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.